Insulet
PODD
#1019
Rank
HK$145.28 B
Marketcap
HK$2,071
Share price
3.90%
Change (1 day)
22.68%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): HK$13.47

According to Insulet's latest financial reports the company's current EPS (TTM) is HK$13.36. In 2022 the company made an earnings per share (EPS) of HK$0.54 a decrease over its 2021 EPS that were of HK$1.79.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$13.472377.33%
2022HK$0.54-69.57%
2021HK$1.79109.09%
2020HK$0.85-38.89%
2019HK$1.40200%
2018HK$0.47-113.04%
2017-HK$3.57-9.8%
2016-HK$3.96-60.77%
2015-HK$10.1039.78%
2014-HK$7.2312.05%
2013-HK$6.45-23.15%
2012-HK$8.3910.2%
2011-HK$7.61-36.36%
2010-HK$11.97-36.63%
2009-HK$18.88-29.36%
2008-HK$26.73-86.74%
2007-HK$201.60-64.04%
2006-HK$560.61122.23%
2005-HK$252.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$15.70-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$25.10-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.61-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.44 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.09 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$21.13 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
HK$42.19 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA